BioEngine deployment . . .
This is comforting to hear, and I believe the report is true, but we shouldn't make more out of it than is there. After all, IDX didn't release this information because it could lead to some unwarranted conclusions.
As isit4real noted in his Yahoo post, there aren't 400 biometrics companies out there, so we are dealing with potential application developers. If there were much money involved at this stage, we probably would have seen something out of Identix. Instead, we are looking at potential. If an application uses BioEngine, IDX would get continuing royalties from its sales.
Let's look at it from the developer's point of view: You want to make money from a new application, so you spend a little money to get rights to play with the IDX BioEngine. You may also spend some money to try out other, competing bioengines, as well. Getting the license doesn't commit you to anything.
But it is nice to know the size of the potential developers' universe, and I would be surprised if anyone else has quite this number of licensees. This is an effort by Identix to have their intellectual property become the de facto biometric standard, and it's a good move. |
